The pharmacy repackaging systems market has seen considerable growth due to a variety of factors.
• The pharmacy repackaging systems market has grown strongly in recent years. It is projected to rise from $2.17 billion in 2024 to $2.38 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%.
The growth is attributed to greater awareness of automated systems, increased cost savings in hospital pharmacies, a need for improved dosage accuracy, rising patient adherence, and the adoption of blister card packaging systems.
The pharmacy repackaging systems market is expected to maintain its strong growth trajectory in upcoming years.
• The pharmacy repackaging systems market is forecasted to reach $3.44 billion by 2029, growing at a CAGR of 9.6%.
The growth is attributed to the adoption of pharmacy automation, the need to reduce medication errors, demand for cost-effective medication management solutions, and chronic disease prevalence. Trends include hyper-automation with robotics, multi-compartment pouches for personalized regimens, ecological packaging, product innovations, and pharmacy collaborations.
The growth of the pharmacy repackaging systems market is anticipated to be fuelled by the increasing occurrence of chronic illnesses. Chronic diseases are typically progressive, long-term medical conditions that are usually constant and often endure for over a year, necessitating continuous medical care or restricting routine activities. The rising rate of these diseases is predominantly attributed to ageing populations, lifestyle shifts such as inadequate diets and lack of physical activity, growing urbanization, and related environmental influences. Pharmacy repackaging systems are crucial for managing chronic diseases effectively, as they ensure correct medication management, improve compliance, and augment patient safety by efficiently dispensing patient-specific doses. The US-based government agency, National Institutes of Health, predicted in January 2023 that the number of people with at least one chronic illness will skyrocket by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. As such, the escalating occurrence of chronic diseases is bolstering the growth of the pharmacy repackaging systems market.
The pharmacy repackaging systems market covered in this report is segmented –
1) By Type: Blister Card Packaging Systems, Pouch Packaging Automation Systems, Liquid Medication Packaging Systems, Bottle Filling Automation Systems
2) By Dosage Type: Unit Dose Packaging, Multiple Unit Packaging
3) By End Use: Retail Or Community Pharmacies, Hospital Pharmacies, Long-Term Care (LTC) Pharmacies, Mail Order Pharmacies
Subsegments:
1) By Blister Card Packaging Systems: Manual Blister Card Packaging, Semi-Automatic Blister Card Systems, Fully Automatic Blister Packaging Systems
2) By Pouch Packaging Automation Systems: Single-Use Pouch Packaging, Multi-Dose Pouch Systems, Automatic Pouch Sealing and Filling Systems
3) By Liquid Medication Packaging Systems: Vial Filling Systems, Syringe and Ampoule Filling Systems, Bottle Liquid Filling and Capping Systems, Bottle Filling Automation Systems
4) By Bottle Filling Systems: Single-Stage Bottle Filling Systems, Multi-Stage Filling and Capping Systems, High-Speed Bottle Filling Systems
Significant players in the pharmacy repackaging systems market, such as MEDISCA Plattsburgh, are strengthening their infrastructure by incorporating automated repackaging systems. This move aims to satisfy the escalating need for precise medication administration across global healthcare facilities. These high-tech repackaging machines are designed to encapsulate medications in different formats correctly, curtailing human error, and boosting efficiency. In June 2024, for example, US-based MEDISCA Plattsburgh inaugurated a new facility for pharmaceutical repackaging, mirroring the rising necessity for personalized medication. By utilizing cutting-edge equipment for exact dosage computation and progressive labeling technology, this facility greatly enhances Medisca's ability to provide bespoke medication repackaging services. Medisca, thus, can deliver top-notch, tailor-made pharmaceutical postulations to its international clientele while ensuring punctual delivery and compliance with regulatory norms. This establishment comes equipped with ISO-certified production rooms and sophisticated warehouse management systems, thereby offering full-fledged traceability. This setup ensures the delivery of superior quality products, along with ensuring the safety of personnel.
Major companies operating in the pharmacy repackaging systems market are:
• McKesson Corporation
• Becton Dickinson & Company
• Baxter International Inc.
• Syntegon Technology GmbH
• Omnicell Inc.
• ACG Worldwide
• Swisslog Holding Ltd.
• Scriptpro LLC
• Capsa Healthcare
• Dossier Systems
• Healthmark
• ARxIUM
• Fulcrum Inc.
• Yuyama Co. Ltd.
• Kirby Lester
• Medical Packaging inc. LLC
• RxSafe LLC
• Deenova S.r.l.
• Meditec
• Noritsu Pharmacy Automation
• Pearson Medical Technologies
• Takazono Corporation
North America was the largest region in the pharmacy repackaging systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacy repackaging systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.